Let's Talk
Back to Insights

Healthcare Shake‑Up: Time to Cut Thermo Fisher and Chase Lilly’s Momentum?

TMO’s slide killed the momentum, so Bill Baruch rotated out and into LLY’s breakout strength. He’s betting LLY earnings surge can fuel a run through June. Watch the full discussion here.

Share

Latest Insights

Our team at Blue Line Capital, led by founder Bill Baruch, shares their expertise and unique market perspective.
  • 1 min read

Reading the Cycle — Bill Baruch Trims Amazon and Alphabet Ahead of June

  • 1 min read

Still Bullish, Just Being Smart — Bill Baruch Trims Nvidia

  • 1 min read

Activating the Trims — Bill Baruch Puts His Final Trades in Eli Lilly, Dominion Energy, and Apple

  • 1 min read

Has Micron Euphoria Peaked? — Bill Baruch Trims

View All Insights